Most actively traded companies on the TSX, TSX Venture Exchange markets

The Canadian Press 0

TORONTO – Some of the most active companies traded Monday on the Toronto Stock Exchange and the TSX Venture Exchange:

Toronto Stock Exchange (13,184.41 up 58.71 points):

TriAusMin Ltd. (TSX:TOR). Mine exploration. Unchanged at three cents on 22.60 million shares.

Brigus Gold Corp. (TSX:BRD). Up 21 cents, or 33.33 per cent, at 84 cents on 20.17 million shares. Primero Mining Corp. (TSX:P) has a friendly deal to acquire Brigus in an all-stock transaction valued at about $220 million. The deal values Brigus shares at 91 cents each. Primero’s stock fell 35 cents, or 6.71 per cent, to $4.87 on 3.29 million shares.

Santonia Energy Inc. (TSX:STE). Oil and gas. Up five cents, or four per cent, at $1.30 on 8.22 million shares.

Manulife Financial Corp. (TSX:MFC). Insurance. Up eight cents, or 0.41 per cent, at $19.73 on 4.97 million shares.

Carpathian Gold Inc. (TSX:CPN). Miner. Up two cents, or 26.67 per cent, at 9.5 cents on 4.93 million shares. A subsidiary of the Toronto-based company received a permit Friday to proceed with the full operation of its gold project in Brazil.

Toronto Venture Exchange (890.66 down 3.81 points):

Border Petroleum Corp. (TSXV:BOR). Oil and gas. Down half a cent, or 50 per cent, at half a cent on 6.89 million shares.

Xmet Inc. (TSXV:XME). Mine exploration. Down a penny, or 6.90 per cent, at 13.5 cents on 5.81 million shares.

Companies reporting major news:

BlackBerry (TSX:BB). Wireless technology. Up 13 cents, or 2.02 per cent, at $6.55 on 1.27 million shares. Two more executives are leaving the struggling smartphone maker amid sweeping changes under interim CEO John Chen. BlackBerry reports its third-quarter results Friday.

Valeant Pharmaceuticals International Inc. (TSX:VRX). Drug maker. Up $4.45, or 3.94 per cent, at $117.52 on 344,263 shares. Valeant is buying Solta Medical Inc. (Nasdaq:SLTM), a California-based company that makes make medical devices used in anti-aging treatments. The Montreal-area company’s offer of US$2.92 per share for all of Solta Medical Inc.’s stock is valued at US$250 million, a 40 per cent premium to Friday’s closing price for Solta shares on the Nasdaq.

Leave a comment

Your email address will not be published. Required fields are marked *